Abstract
Aim: We conducted a systematic review to study cases of women who reported abnormalities on mammograms following COVID-19 vaccination, and evaluate the proportion of cases that warranted further investigations to rule out breast cancer. Through this, we aimed to evaluate the need for further follow-up radiological investigations such as sonography etc. before invasive investigations were carried out to rule out breast malignancy.
Methods: Electronic Databases of PubMed, and Medline were searched on 18th July 2022, to extract published articles with the keywords: COVID-19 vaccination, Lymphadenopathy, and Mammogram. The publication timeframe of included studies ranged from November 01, 2019, to July 18, 2022. Studies that were published in languages other than English were not considered for this systematic review. In vitro studies, In vivo studies, review articles and short communications were not considered for this systematic review. However, references of reviews were cross-checked for relevant publications.
Results: We identified 20 published results and 9 publications were selected after eliminating reviews, communication articles, and non-research articles 1048 patients were included in the systematic review. with 287 patients reporting significant abnormalities on mammography findings, which would warrant further invasive investigations according to NHS, UK protocols [9]
References
Page J, Hinshaw D, McKay B (26 February 2021). "In Hunt for Covid-19 Origin, Patient Zero Points to Second Wuhan Market – The man with the first confirmed infection of the new coronavirus told the WHO team that his parents had shopped there". The Wall Street Journal. Retrieved 27 February 2021.
WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data
COVID-19 vaccines | Vaccine Knowledge (ox.ac.uk)
Richie H, Ortiz-Ospina E, Beltekian D, Methieu E, Hasell J, Macdonald B, et al. (5 March 2020). "Coronavirus (COVID-19) Vaccinations – Statistics and Research". Our World in Data.
Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer | Breast Cancer | JAMA | JAMA Network
Moderna COVID-19 Vaccine: Vaccines and Related Biological Products Advisory Committee Meeting, December 17, 2020. Accessed September 28, 2021. https://www.fda.gov/media/144434/download
Polack FP, Thomas SJ, Kitchin N, et al; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603-2615. doi:10.1056/NEJMoa2034577
COVID-19 Vaccination–Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women : American Journal of Roentgenology : Vol. 217, No. 4 (AJR) (ajronline.org)
Breast cancer in women - Diagnosis - NHS (www.nhs.uk)
COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases - PubMed (nih.gov)
Adenopathy Following COVID-19 Vaccination - PubMed (nih.gov)
COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women - PubMed (nih.gov)
Unilateral axillary lymphadenopathy following COVID-19 vaccination: A case report and imaging findings - PubMed (nih.gov)
Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination - PubMed (nih.gov)
Time for Resolution of COVID-19 Vaccine-Related Lymphadenopathy and Associated Factors - PubMed (nih.gov)
Transient ipsilateral breast edema following COVID-19 vaccination - PubMed (nih.gov)
Mammographic and sonographic findings in the breast and axillary tail following a COVID-19 vaccine - PubMed (nih.gov)
Mammographic findings of diffuse axillary tail trabecular thickening following immunization with mRNA COVID-19 vaccines: Case series study - PubMed (nih.gov)
Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram | Radiology (rsna.org)
When you'll be invited for breast screening and who should go - NHS (www.nhs.uk)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Array